Add Tribune As Your Trusted Source
TrendingVideosIndia
Opinions | CommentEditorialsThe MiddleLetters to the EditorReflections
UPSC | Exam ScheduleExam Mentor
State | Himachal PradeshPunjabJammu & KashmirHaryanaChhattisgarhMadhya PradeshRajasthanUttarakhandUttar Pradesh
City | ChandigarhAmritsarJalandharLudhianaDelhiPatialaBathindaShaharnama
World | ChinaUnited StatesPakistan
Diaspora
Features | The Tribune ScienceTime CapsuleSpectrumIn-DepthTravelFood
Business | My MoneyAutoZone
News Columns | Straight DriveCanada CallingLondon LetterKashmir AngleJammu JournalInside the CapitalHimachal CallingHill View
Don't Miss
Advertisement

Covaxin production to double by May

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Yearly Premium ₹999 ₹349/Year
Yearly Premium $49 $24.99/Year
Advertisement

BOX

Advertisement

Doses to go up 10-fold by Sept

Advertisement

*The production of indigenous Covaxin to go up from 1 crore doses in April to 7 crore a month by July-August

*The figure will reach nearly 10 crore doses a month by September

Advertisement

BOX

Concern over Covishield

Denmark’s ban on the AstraZeneca vaccine over blood clot issues has again triggered a debate on the safety of Covishield, although Indian authorities have repeatedly said there is nothing to suggest a link between clotting and the vaccine.

BOX: More hospitals roped in

Union Health Secretary has written to Central Ministries to use their hospitals and those under PSUs for Covid patients.

Tribune News Service

New Delhi, April 16

Reeling under the record Covid-19 daily surge that touched 2,17, 353 cases today, the government said it would double the production of indigenous Covaxin by May, and increase it nearly seven-fold by August.

Hoping to escalate vaccinations as tools to beat the severe disease while hospitals fill up, the Centre also said that Rs 65-crore grant would be extended to Bharat Biotech’s new Bangalore facility.

The government in a statement today said, “The current production capacity of the Bharat Biotech-ICMR jab Covaxin will be doubled by May-June and then increased nearly six to seven-fold by July and August. The production will be raised from 1 crore vaccine doses in April this year to 7 crore vaccine doses a month by July-August. It is expected to reach nearly 10 crore doses per month by September 2021.”

Three public sectors companies have also been asked to augment vaccine supplies for domestic use.

Haffkine Biopharmaceutical Corporation, Mumbai, a Maharashtra Government enterprise which had earlier sought 12 months to reach production capacity of 20 million doses of Covaxin a month, has now been told by the Centre to compress its timeline to six months.

Indian Immunologicals Ltd, Hyderabad, and Bharat Immunologicals and Biologicals Limited, Bulandshahr, will also be supported to prepare for producing 10 to 15 million doses of Covaxin a month by August.

The active Covid-19 cases today crossed 15 lakh to settle at 15,69,743, which is 10.98 per cent of all cases. India saw more than 2 lakh daily cases for the second consecutive day today.

Advertisement
Show comments
Advertisement